Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Elizabeth Koller"'
Publikováno v:
Pharmacotherapy. 23:1123-1130
Study Objective. To investigate the relative numbers and clinical characteristics of pancreatitis in patients treated with the atypical antipsychotic agents, clozapine, olanzapine, and risperidone, versus the conventional neuroleptic, haloperidol. De
Autor:
Elizabeth Koller, P. Murali Doraiswamy
Publikováno v:
Pharmacotherapy. 22:841-852
Study Objective. To explore the clinical characteristics of hyperglycemia in patients treated with olanzapine. Design. Retrospective, epidemiologic survey of spontaneously reported adverse events related to olanzapine therapy. Setting. Government-aff
Publikováno v:
AIDS Patient Care and STDs. 13:287-295
This report summarizes postmarketing adverse events reported to the Food and Drug Administration (FDA) that describe unusual or abnormal fat distribution in association with anti-retroviral therapies. Reports associated will protease inhibitors were
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 83:2380-2383
A role for GH in the pathogenesis of diabetic retinopathy has long been postulated. Previous clinical studies, however, have been confounded by hyperglycemia. We have identified 2 cases of retinopathy associated with exogenous GH therapy in nondiabet
Publikováno v:
The Journal of clinical psychiatry. 65(6)
Objective To explore the clinical characteristics of hyperglycemia in patients treated with quetiapine. Method A pharmacovigilance survey of spontaneously reported adverse events in quetiapine-treated patients was conducted using reports from the U.S
Publikováno v:
Nutrition (Burbank, Los Angeles County, Calif.). 15(4)
Autor:
Janos Bacsanyi, Marianne Mann, Matthew Leinung, Elizabeth Koller, Saul Malozowski, Anthony J. Murgo
Publikováno v:
Archives of internal medicine. 157(15)
Sporadic single case reports linking glucocorticoidlike activity to megestrol acetate have been reported in the literature. These findings have important implications for patient care. Adverse drug experience reports to the US Food and Drug Administr
Publikováno v:
Pediatrics. 113:421-422
To the Editor .— The elegant trial by Turgay et al1 highlights the emerging promise of risperidone to treat behavioral disturbances in children. Although the study found that risperidone was useful and safe in children for up to 48 weeks, weight ga
Publikováno v:
Chest. 119:1291-1292
Autor:
Elizabeth Koller, Saul Malozowski
Publikováno v:
Chest. 119:988-989